10.1038/s41467-020-20442-3 - HIV-1 diversity considerations in the...

This document has been corrected

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

10.1038/s41467-020-20442-3

Published Online: 2021-01-08

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Andrew Wilson•Aniqa Shahid•Avery Wimpelberg•Chanson J. Brumme•Christopher Cannon•Colin Kovacs•Don Kirkby•Erika Benko•Guinevere Q. Lee•Harris Goldstein•Lynsay MacLaren•Marianne Harris•Mario A. Ostrowski•Natalie N. Kinloch•Perla M. Del Rio Estrada•Pragya Khadka•R. Brad Jones•Rebecca M. Lynch•Szu Han Huang•Talia M. Mota•W. David Hardy•Winiffer D. Conce Alberto•Winnie Dong•Yanqin Ren•Zabrina L. Brumme

This document has been corrected

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

10.1038/s41467-020-20442-3

Published Online: 2021-01-08

Journal: Nature Communications

NOW

2021-05-13•Correction

Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

10.1038/s41467-021-23515-z

* information provided by CrossRef

2021-05-13•Correction

10.1038/s41467-021-23515-z

* information provided by CrossRef

2021-01-08•Published

2021-05-13•Correction

Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

10.1038/s41467-021-23515-z

* information provided by CrossRef

This document has been corrected

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

10.1038/s41467-020-20442-3

Published Online: 2021-01-08

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC